Skip to main content
. 2025 May 12;8:e64372. doi: 10.2196/64372

Table 1. Demographics, comorbidities, and mobility characteristics of the patients.

Variables Experiment 1 Experiment 2
Demographics, n 25 30
Age (y), mean (SD) 79.6 (8.1) 81.4 (8.8)
Sex (female), n (%) 17 (65) 24 (80)
BMI (kg/m2), mean (SD) 25.6 (6.2) 25.2 (7.7)
Gait aids, n (%) 25 (100) 29 (100)
None 12 (48) 7 (24)
Walker rollator 12 (48) 16 (55)
Cane 1 (4)
2 (6)
Cane and walker 0 4 (14)
Most common comorbidities, n 30 c
Cardiac condition (hypertension, congestive heart failure, atrial fibrillation, and coronary artery disease) 25
Diabetes 9
Osteoarthritis 8
Cancer 7
COPDb and Asthma 7
Osteoporosis 5
Kidney disease 5
Early diagnosis of Alzheimer 2
Parkinson 2
Mobility before admission, n (%) 30 (100)
Independent 8 (27)
Independent with cane 3 (10)
Independent with walker 15 (50)
1 Person assist 1 (3)
1 Person assist with walker 2 (7)
Independent with cane inside and walker outside 1 (3)
Mobility after admission N=30
Independent 1 (3)
Independent with cane 1 (3)
Independent with walker 11 (37)
1 Person assist 3 (10)
1 Person assist with walker 14 (47)
Mobility tests, n 23
TUGa (s)
Mean (SD) 28.5 (13.7)
Median (IQR) 23.3 (7.14-61.0)
Average speed (m/s)
Mean (SD) 0.27 (0.16)
Median (IQR) 0.22 (0.09-0.84)
30MWTd (m-s) test 1
Mean (SD) (s)
50 (31)
Median (IQR) (s) 35 (30-120)
Percentile 25 (s) 32
Percentile 75 (s) 67
30MWT (m-s) retest
Mean (SD) (s)
58 (17)
Median (IQR) (s) 20 (30-50)
Percentile 25 (s) 50
Percentile 75 (s) 70
a

TUG: timed up and go.

b

COPD: chronic obstructive pulmonary disease.

c

Not applicable.

d

30MWT: 30-meter walking test.